Compounds > tolbutamide
Page last updated: 2024-08-16

tolbutamide and deferoxamine

tolbutamide has been researched along with deferoxamine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19903 (42.86)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y1
Faigle, JW; Fritz, H; Keberle, H; Loustalot, P; Schmid, K1
de Haan, BB; Pometta, D; Scherrer, JR; Stauffacher, W1
Ghidoni, A; Pozza, G1

Reviews

1 review(s) available for tolbutamide and deferoxamine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

6 other study(ies) available for tolbutamide and deferoxamine

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
    Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16

    Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone

2016
[On the penetration of foreign body materials into the young vertebrate embryo].
    Bulletin der Schweizerischen Akademie der Medizinischen Wissenschaften, 1966, Volume: 22, Issue:1

    Topics: Animals; Deferoxamine; Embryo Implantation; Embryo, Mammalian; Female; Glycosaminoglycans; Lipids; Pregnancy; Rabbits; Thalidomide; Tolbutamide

1966
Iron excess, early glucose intolerance and impaired insulin secretion in idiopathic haemochromatosis.
    European journal of clinical investigation, 1973, Volume: 3, Issue:3

    Topics: Adolescent; Adult; Age Factors; Blood Glucose; Deferoxamine; Diabetes Mellitus; Female; Glucose Tolerance Test; Hemochromatosis; Humans; Insulin; Iron; Male; Middle Aged; Pedigree; Protein Binding; Tolbutamide

1973
Studies on the diabetic syndrome of idiopathic haemochromatosis.
    Diabetologia, 1968, Volume: 4, Issue:2

    Topics: Adult; Aged; Blood Glucose; Deferoxamine; Diabetes Mellitus; Glucose Tolerance Test; Hemochromatosis; Humans; Insulin; Male; Tolbutamide

1968